MYOK
RhumbLine Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-66,022
| Closed | -$9M | – | 3058 |
|
|
2020
Q3 | $9M | Sell |
66,022
-13,671
| -17% | -$1.86M | 0.01% | 832 |
|
|
2020
Q2 | $7.7M | Buy |
79,693
+15,804
| +25% | +$1.53M | 0.01% | 915 |
|
|
2020
Q1 | $3M | Buy |
63,889
+1,710
| +3% | +$80.2K | 0.01% | 1328 |
|
|
2019
Q4 | $4.53M | Buy |
62,179
+2,852
| +5% | +$208K | 0.01% | 1314 |
|
|
2019
Q3 | $3.09M | Buy |
59,327
+891
| +2% | +$46.5K | 0.01% | 1473 |
|
|
2019
Q2 | $2.93M | Buy |
58,436
+13,536
| +30% | +$679K | 0.01% | 1497 |
|
|
2019
Q1 | $2.33M | Buy |
44,900
+15
| +0% | +$780 | ﹤0.01% | 1623 |
|
|
2018
Q4 | $2.19M | Buy |
44,885
+14,676
| +49% | +$717K | ﹤0.01% | 1585 |
|
|
2018
Q3 | $1.97M | Buy |
30,209
+981
| +3% | +$64K | ﹤0.01% | 1669 |
|
|
2018
Q2 | $1.45M | Buy |
29,228
+10,579
| +57% | +$525K | ﹤0.01% | 1845 |
|
|
2018
Q1 | $910K | Sell |
18,649
-21
| -0.1% | -$1.03K | ﹤0.01% | 1982 |
|
|
2017
Q4 | $786K | Sell |
18,670
-2,118
| -10% | -$89.2K | ﹤0.01% | 2055 |
|
|
2017
Q3 | $891K | Buy |
20,788
+2,299
| +12% | +$98.5K | ﹤0.01% | 2031 |
|
|
2017
Q2 | $242K | Buy |
18,489
+5,773
| +45% | +$75.6K | ﹤0.01% | 2659 |
|
|
2017
Q1 | $167K | Buy |
12,716
+858
| +7% | +$11.3K | ﹤0.01% | 2696 |
|
|
2016
Q4 | $154K | Buy |
+11,858
| New | +$154K | ﹤0.01% | 2735 |
|